Compare UUUU & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UUUU | ACLX |
|---|---|---|
| Founded | 1987 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | N/A | 2022 |
| Metric | UUUU | ACLX |
|---|---|---|
| Price | $21.90 | $67.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $17.80 | ★ $113.75 |
| AVG Volume (30 Days) | ★ 18.3M | 856.7K |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $78,742,000.00 | $35,898,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $174.53 | $309.32 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 103.69 | N/A |
| 52 Week Low | $3.20 | $47.86 |
| 52 Week High | $27.90 | $94.07 |
| Indicator | UUUU | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 51.38 | 46.76 |
| Support Level | $19.45 | $66.44 |
| Resistance Level | $23.27 | $71.25 |
| Average True Range (ATR) | 2.81 | 2.72 |
| MACD | -0.48 | 0.03 |
| Stochastic Oscillator | 28.34 | 26.48 |
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.